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APPROACH:
The DNA alphabet is not limited to the four standard nucleotides known in natural DNA. Rather, twelve nucleobases forming six base pairs joined by mutually exclusive hydrogen bonding patterns are possible within the geometry of the Watson-Crick base pair. The PI and his group have developed the chemistry and enzymology of these nucleobases, which are now known as An Expanded Genetic Information System (AEGIS) . AEGIS is a new, "rule based" molecular recognition system that carries much of the functionality of proteins, can be prepared in combinatorial form, and can be copied and amplified much like nucleic acids. Figure 1 shows some of the standard and nonstandard base pairs.
One of the "Holy Grails" in the molecular sciences is a method to generate receptors, ligands, and catalysts "on demand", without the need for design. A variety of combinatorial technologies has emerged that search for these molecules among a collection of molecules of random structure. For example, a combinatorial technique known as in vitro selection (IVS) has been developed by Szostak, Ellington, Gold, Joyce, Cech and others to obtain DNA and RNA receptors, ligands (often called aptamers), and catalysts (often called ribozymes) on demand ( Figure 2 ). The approach begins with a library of oligonucleotides of random sequence, typically 10 14 individual DNA molecules. The library is passed through an affinity column bearing the "target" receptor. Oligonucleotides from the library that bind to the receptor are retained on the column, to be later eluted and amplified using the polymerase chain reaction (PCR). The amplification is coupled with mutation, to generate a new library of oligonucleotides, related by descent to DNA molecules that had some affinity to the receptor. Some of the mutants bind the receptor better than their parents; some bind worse. Repeating the selection extracts the former preferentially, and the cycle is repeated to yield aptamers that bind to the target receptor. If a small molecule ligand is attached to the column, then the procedure can yield DNA and/or RNA receptors that bind the ligand. Likewise, "ribozymes" and "deoxyribozymes" that catalyze reactions can be obtained by IVS if, through its catalytic power, an oligonucleotide that catalyzes a reaction is separated from oligonucleotides that do not.
DNA-and RNA-based ligands and receptors have been raised against a variety of targets, including nucleic acids, proteins, peptides and small organic molecules. However, a decade of experimental work has shown that the catalytic power of ribozymes and the affinity of aptamers is frequently disappointing, especially for reactions and ligands that are not themselves nucleic acids.
The limitations of deoxyribozymes generated by IVS experiments are due in large part to the absence of chemical functionality on DNA and RNA, especially when compared with the functionality found on proteins. In particular, DNA and RNA libraries contain no positive charge, no functional groups (such as imidazole) that serve effectively as general acids and general bases near pH 7, and no non-aromatic hydrophobicity. Therefore, the aptamers and ribozymes obtained from standard IVS experiments with natural nucleic acids are limited in scope, especially when compared with the corresponding protein antibodies or enzymes.
AEGIS offers the opportunity to circumvent these limitations. The range of functionality available to the aptamer library pool can be expanded by introducing functionality onto nucleobases. The task targeted by the ONR was to develop an Expanded Combinatorial Selection (EXCSEL) tool that could generate receptors (for trinitrotoluene, for example) and catalysts (for degrading hazardous materials on Navy sites being closed and returned to civilian jurisdiction, for example), that could be applied to Navy needs.
Central to this goal is the development of DNA and RNA polymerases that will accept components of AEGIS. This has proven to be a challenging task. Our understanding of polymerases is inadequate to support an effort to directly design enzymes that accept these components. We have, of course, clones of various polymerases and the molecular biological tools needed to substitute specific amino acids in the sequence for others. The interactions between polymerases and components of AEGIS are subtle, however, and chemical theory is simply inadequate to predict what amino acid substitutions will generate the desired effects. Therefore, "directed evolution" (of the type used by Frances Arnold) experiments have been done with polymerases. These have been supported by the equipment purchased with this grant.
ACCOMPLISHMENTS:
Some 100 polymerases and naturally occurring variants of these have been examined, many using the equipment purchased under this grant. A proximity scintillation assay has been developed to support a "high throughput" screen of polymerases obtained via directed evolution. The first in Introduction. -The Watson-Crick base pairing between two complementary oligonucleotide strands remains one of the most remarkable examples of molecular recognition. It follows two rules of complementarity: i) a large purine from one strand pairs with a small pyrimidine from the other; ii) H-bond donors (NH groups) of one base pair with H-bond acceptors (lone pairs of electrons on an O-or N-atom) of the other. Nature only partially exploits the potential of the Watson-Crick formalism, however. Structures for six base pairs can readily be written to conform to Watson-Crick geometry [1] [2] . Therefore, it is possible, in principle, to have twelve independently replicating 'letters' in the nucleoside 'alphabet'.
One feasible non-standard base pair is formed between 2'-deoxyisocytidine (isoC d , la) and 2'-deoxyisoguanosine (isoG d , 2a), held together by three H-bonds like a G • C base pair. It was suggested three decades ago by Rich [3] that the isoG • isoC base pair might have been a component of primitive nucleic acids early in the development of life. In the late 1980's, the first experimental work was done to explore the oligonucleotide chemistry of this non-standard base pair, including its ability to be incorporated by enzymatic template-directed polymerization. Since then, several other laboratories have made major contributions to developing the chemistry and enzymology of the isoC • isoG base pair, including those of Tor and Dervan [4] , Horn et al. [5] , Seela and Wei [6] and Switzer et al. [7] . This work has shown, inter alia, that these bases can pair in both an antiparallel duplex as well as a parallel duplex, with similar stability to a guanine and cytosine base pair [5] [8] [9] [10] . Further, a variety of RNA and DNA polymerases have been found that catalyze template-directed incorporation of this base pair into DNA [7] . 
Despite the structural similarities that isoG and isoC share with the standard bases, it has not been trivial to convert procedures and protecting groups used for the automated solid-phase synthesis of standard oligonucleotides to be suitable for preparing oligonucleotides containing isoC and isoG. For example, Switzer and coworkers [9] reported that formamidine-protected 2'-deoxyisocytidine underwent rapid depyrimidination under conditions used routinely for the deprotection of oligonucleotides containing standard nucleobases. In contrast, Horn et al. [5] mentioned no such problem in their work. We found that isoQ as its benzoyl-protected derivative underwent deamination under basic oligonucleotide-deprotection conditions [7] . Likewise, Strobel et al. [11] reported that 5-methylisocytidine derivatives deaminated when subjected to these conditions. Horn et al. [5] , however, reported no deamination upon basic deprotection of synthetic oligonucleotides using formamidine-protected 2'-deoxy-5-methylisocytidine phosphoramidites, although they did report depyrimidination 'precluding incorporation of more than a single disoMeC residue' into an oligonucleotide when the disoMeC (= me 5 isoC d ) nucleobase was protected as a benzoate. In contrast, Tor and Dervan [4] reported neither depyrimidination nor deamination in oligonucleotide syntheses with the same benzoyl-protected me 5 isoC d . Similar incongruitites can be found in the literature reporting the synthesis of oligonucleotides containing isoG. Roberts et al. [8] [9] and Sugiyama et al. [10] mentioned no difficulties using standard solid-phase procedures to prepare oligonucleotides containing the phosphoramidite of 2'-deoxyisoguanosine protected as the A^N-formamidine and 0 2 -diphenylcarbamylate (dpc) ester. Horn et al. [5] reported, however, that dpc-protected isoG phosphoramidite 'may be too acid-labile for practical use'. Seela and Wei [6] noted that solid-phase synthesis with 2'-deoxyisoguanosine using phosphoramidites and phosphonates gave low yields with consecutive incorporations, and suggested that a modified phosphonate synthesis be used for oligomers containing multiple consecutive isoG residues.
In view of the importance of the non-standard base pair in a variety of areas, most interestingly in DNA-based diagnostics [5] [12] , it is timely to report a detailed study containing full experimental recipes describing the chemistry for the synthesis of oligonucleotides containing isoQ and isoG d . In this work, we develop syntheses and evaluate the utility of various protecting groups for phosphoramidites of isoC d and isoG d in automated synthesis, exploring and resolving some of the incongruities noted above.
Results and Discussion. -Isocytidine. Because of reports that deamination was suppressed by a 5-methyl substituent in isoC [4] {Scheme 1), this work focused on protected variants of this derivative. Thus, # 2 -benzoyl-2'-deoxy-5'-0-(4,4'-dimethoxytrityl)-5-methylisocytidine 3'-(2-cyanoethyl diisopropylphosphoramidite) (lc) was prepared following the general procedure of Tor and Dervan, with two improvements that significantly increased the yields. First, use of a Parr pressure reactor for the treatment of 2,5'-anhydrothymidine (3) with ammonia resulted in an improved, nearly quantitative yield of 2'-deoxy-5-methylisocytidine (Id). The synthetic results were also improved by Chromatographie purification (silica gel) of the tritylated derivative If immediately following its formation from le, without storage. After modification, the overall yield for the three steps producing lc from 2'-deoxy-5-methylisocytidine (Id) was 36%.
When used in a standard oligonucleotide synthesis, 7V 2 -benzoyl-2'-deoxy-5'-0-(4,4'-dimethoxytrityl)-5-methylisocytidine 3'-(2-cyanoethyl diisopropylphosphoramidite) (lb) did not perform satisfactorily in our hands. The trityl release following coupling of the non-standard nucleotide derivative dropped precipitously, and very little full-length product was detected upon completion of the synthesis. An analogous observation was made by Horn et ah [5] . These authors proposed that the low coupling yield arose due to depyrimidination, and they suggested the use of formamidine protection to avoid this problem.
Depyrimidination occurs during the acidic detritylation steps employed in automated synthesis, so the efficacies of several detritylation reagents on the model compound 5'-0-(4,4'-dimethoxytrityl)thymidine ([(MeO) 2 Tr]T d ) were investigated. Three detritylation reagents proposed for oligonucleotide synthesis were examined: CCl 3 COOH, ZnBr 2 [13] , and eerie ammonium nitrate [14] . CCl 3 COOH (1%) in 1,2-dichloroethane and ZnBr 2 in MeN0 2 /PhN0 2 4:1 both detritylated [(MeO) 2 Tr]T d almost instantaneously at room temperature. Interestingly, a substantial amount of (MeO) 2 Tr-protected thymidine remained after 15 min when eerie ammonium nitrate in wet MeCN or wet MeCN/DMF was used. 7V 2 -Benzoyl-2'-deoxy-5-methylisocytidine (le) and the formamidine-derived 2'-deoxy-7V 2 -[(dimethylamino)methylidene]-5-methylisocytidine (lg) were treated with the three detritylating reagents at room temperature (see Table) . The resulting mixtures were quenched and then analyzed on reversed-phase HPLC, monitoring at 260 nm. The /V^-benzoyl derivative le degraded completely in less than 15 min in the CCl 3 COOH and ZnBr 2 solutions. In solutions containing eerie ammonium nitrate, le decomposed more slowly, but the detritylation of the corresponding trityl derivative If was also slower, with depyrimidination faster than detritylation. A larger sample of the only decomposition product absorbing at 260 nm observed after exposure of le to the detritylation conditions was generated with CCl 3 COOH and confirmed as 5-methylisocytosine by 'H-NMR. The corresponding formamidine-protected 7V 2 -[(dimethylamino)methylidene] derivative lg was considerably more stable. After 1 h in the CCl 3 COOH solution, only ca. 1 % of the compound was degraded (UV). In the presence of ZnBr 2 , no depyrimidination of lg was detected after 1 h at room temperature. Even after a further 16 h at 40°, only ca. 2% degradation was detected.
^1 A A
To evaluate the stability of lg with respect to deamination, the compound was exposed to standard cleavage/deprotection conditions used in automated synthesis. A small amount of lg was placed in 25 % aqueous ammonium hydroxide and heated at 60° for 16 h. The solvent was removed under vacuum, the residue dissolved in water, and the mixture resolved by HPLC. Prior to treatment, UV analysis of an HPLC chromatogram showed lg to account for 99 % of the material absorbing at 260 nm. Following treatment, 2'-deoxy-5-methylisocytidine (Id) accounted for 96% of the material. Thymidine (perhaps 2%, verified by addition of authentic thymidine) was the only detectable impurity, corresponding to the deamination product of Id.
These results show that /V r2 -benzoyl-2'-deoxy-5-methylisocytidine (le) is too acidlabile for practical use; it was even labile under non-pro tic detritylation conditions. The successful use of this compound in oligonucleotide synthesis by Tor and Dervan [4] might be ascribed to the fact that the oligonucleotide prepared contained a single isoC residue close to the 5'-end of the oligomer, and therefore did not need to survive many cycles of treatment under detritylation conditions.
In contrast, the formamidine-protected 5-methylisocytidine lg appears suitable for phosphoramidite automated synthesis, displaying only small amounts of depyrimidination and (perhaps) deamination. The dimethylformamidine derivative lg used in the stability study, however, has been reported as labile under DNA-synthesis conditions [15] . Therefore, 2'-deoxy-/V r2 -[(diisobutylamino)methylidene]-5'-0-(4,4'-dimethoxytrityl)-5-methylisocytidine 3'-(2-cyanoethyl diisopropylphosphoramidite) (lj), bearing the more stable diisobutylformamidine protecting moiety, was synthesized in three steps from 2'-deoxy-5-methylisocytidine (Id). Reaction with /V,./V-diisobutylformamidine dimethyl acetal gave the easily-purified /V r2 -protected isocytidine lh after 1 h {Scheme 4). The fully protected target phosphoramidite lj was readily isolated in an overall yield of 38 % for the three steps via lh and li starting with Id.
Additionally, a method adapted from a procedure for recycling unused phosphoramidites from an automated synthesizer [16] , proceeding through intermediates 11 and lm, was developed to convert existing benzoyl-protected phosphoramidite into formamidine-protected phosphoramidite (lc -> 11 -> If -> lm; see Exper. Part).
Phosphoramidite lj was examined for utility for synthesizing oligonucleotides containing isoC. Although ZnBr 2 was (from the studies above with lg) a superior detritylat-ing reagent without depyrimidination, it was decided to first use standard detritylating conditions (CCl 3 COOH), which also performed well in the stability study. The three oligonucleotides 4-6 were synthesized to test the efficacy of phosphoramidite lj.
A PAGE autoradiogram and an anion-exchange HPLC (Fig. 1 ) of the crude synthetic oligonucleotide 4 showed small amounts of failure products (albeit greater than seen with standard bases). Nevertheless, the synthesis yielded a satisfactory amount of full-length oligonucleotide 4. The synthesis of crude oligonucleotide 5 gave similar results. After deprotection and desalting, the crude mixtures containing 4 or 5 were purified by ion-exchange HPLC, followed by reversed-phase HPLC. To verify the identity of the major product, the purified oligonucleotides 4 and 5 were digested by snake-venom phosphodiesterase and alkaline phosphatase and analyzed by reversed-phase HPLC. The component nucleosides found were consistent with the expected results for digestion of 4 and 5, respectively (Fig. 2) . Notably, no significant peak arising from T d was present in the chromatograms, indicating that deamination did not occur in the oligonucleotides to the same extent as observed in syntheses with nucleoside lb, or even to the extent observed above with the formamidine-protected monomer nucleoside lg.
5'-d(A-iC-iC-iC-iC-iC-iC-iC-iC-iC-iC-C)(4)

5'-d(A-A-A-A-A-iC-iC-iC-iC-iC-A-A-A-A-A)(5)
5'-d(T-T-T-T-T-iC-iC-iC-iC-iC-T-T-T-T-T)(6)
5'-d(T-T-T-T-T-iG-iG-iG-iG-iG-T-T-T-T-T)(10)
5'-d(C-A-C-A-A-iG-A-iG-A-iG-A-A-C-A) (11)
Oligonucleotide syntheses are frequently followed by quantifying the amount of trityl cation released. The isoC d -containing oligonucleotide 6 was synthesized to evaluate coupling during synthesis by analyzing the integrated absorbance of released (MeO) 2 Tr protecting group at each added base. The efficiency of synthesis of the first part of oligonucleotide 6 was determined from couplings 2-4, the second part (containing isoC d ) from couplings 5-9, and the final part from couplings 10-14. The coupling efficiency of the isoC d -derived phosphoramidites was 99.5%, comparable to the 99.9% efficiency for coupling in the other two sections containing only T d .
Isoguanosine. Synthesis of oligonucleotides containing 2'-deoxyisoguanosine has been previously reported by Switzer et al. [7] using the 2'-deoxy-Af
To avoid the use of 1,8-diazabicyclo [5.4 .0]undec-7-ena (DBU) in the deprotection procedure, the diphenylcarbamoyl moiety has been suggested for protecting the 2-O-position [5] [9] . This protecting group has been used successfully for incorporation of 2'-deoxyisoguanosine using phosphonate chemistry [6] , and evidently helps stabilize the ,/V-glycoside bond from acid-catalyzed hydrolysis [6] .
Thus, 2'-deoxy-
was first synthesized in 7 steps (Scheme 2) from 2'-deoxy-2-aminoadenosine (7a). Although this synthesis is satisfactory for small amounts of the target phosphoramidite 7e, 
we required a procedure amenable to large-scale work. Unfortunately, the starting material 7a in this route is quite expensive. Consequently, an alternative route starting with the relatively inexpensive ribose compound, 2-aminoadenosine (7f), was designed.
Scheme 2 Originally the intermediate 8 was planned in the synthesis of 7e from 7f. Reaction of 2d with l,3-dichloro-l,l,3,3-tetraisopropyldisiloxane gave a ca. 1:1 mixture ('H-NMR) of 8 and 2e {Scheme 3), however. Problems forming the eight-membered cycle bridging the O-atoms at C(3') and C(5') have been observed in other nucleosides. Silylations at the y-O-and 5'-0-positions to give desired product, as well as at an unprotected carbonyl group of the base and the 5'-0-position to give side product, have been observed for unprotected isoG d [17] and for /^-protected isoC [18] . Compounds 8 and 2e were separable, but the resulting poor yield was impracticable. Next, selective 3',5'-di-0-silylation of 2d to 2f was tried (Scheme 3), using a literature procedure for similar reactions [19] ; however, NMR analysis of the product revealed a complex mixture of several inseparable silylated derivatives.
A slightly longer route was then developed to synthesize 7e from the ribose derivative 7f (Scheme 4). The intermediate 2g was purified with much greater ease than the corresponding 2'-deoxy compound 2a (see Scheme 3), and not all synthetic intermediates required isolation. An overall yield of 13 % for 11 steps, producing 7e from the inexpensive starting material 7f via the silylated derivatives 9a-c without side reactions or laborious purifications, make this route suitable for large-scale preparation.
Coupling efficiency with phosphoramidite 7e was evaluated in the same manner as described for the isoC d -derived phosphoramidite lj above. Incorporation of 7e into oligonucleotide 10 yielded little or no target oligomer using standard coupling times. The situation was greatly improved with extended coupling times (Fig. 3) . It proved necessary to extend the coupling times to at least 600 s for each cycle incorporating an isoG d residue to obtain reasonable coupling efficiency. The increase in full-length target oligomer with extended coupling times was verified by ion-exchange HPLC of the crude products. Despite high coupling yields by trityl release, the HPLC indicate significantly more failure products than seen with standard bases, although the full-length oligonucleotide 10 was clearly the major product of the synthesis. The longer coupling time (600 s) needed for the incorporation of the isoG d residue compared to conventional DNA synthesis (ca. 90 s) lacks an explanation. In any case, the coupling time required for oligonucleotide synthesis containing 2'-deoxyisoguanosine is comparable to the coupling time employed in oligoribonucleotide synthesis [20] .
Oligonucleotide 11 was synthesized with extended coupling times (900 s) using phosphoramidite 7e. An anion-exchange HPLC of the crude product indicated that although the trityl-release-monitored coupling efficiency was > 95 %, quite significant amounts of failure products were generated. The crude product was purified by anion-exchange HPLC, followed by reversed-phase HPLC, and the purified oligonucleotide 11 was enzymatically digested as described above. The reversed-phase HPLC of the digestion products are consistent with the expected component nucleosides of 11 (Fig. 4) .
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Experimental Part
General. The 2-aminoadenosine (7f) and 2-amino-2'-deoxyadenosine (7a) were purchased from RI Chemicals, Inc. (Orange, CA), l,3-dichloro-l,l,3,3-tetraisopropyldisiloxane from Farchan Laboratories, Inc. (Gainesville, FL), lff-imidazole from Kodak, and all other chemicals from Aldrich Chemical or Fisher Scientific; they were used without further purification. All materials to make buffer solutions, including K 2 HP0 4 , KC1, Et 3 N, Tris (= tris(hydroxymethyl)aminomethane (= 2-amino-2-(hydroxymethyl)propane-l,3-diol)), HC1, and AcOH were from Fisher, except for KH 2 P0 4 , which was from Mallinckrodt. TsCl was freshly recrystallized from petroleum ether. Solvents were dried over 4-Ä molecular sieves. CH 2 C1 2 used in the synthesis and workup of phosphoramidites was freshly distilled from K 2 C0 3 . All reactions were carried out under dry Ar in an oven-dry glass system. 'Evaporation' refers to removal of volatile solvents with a membrane pump. Column chromatography (CC): silica gel (230-425 mesh). TLC: silica gel TLC plates from Whatman, visualization by staining with a Ce/Mo reagent (2.5% phosphormolybdic acid, 1 % Ce ,v (S0 4 ) 2 • 4H 2 0, 6% H 2 S0 4 in H 2 0) and heating. HPLC: solvents from Fisher Scientific (HPLC grade) and M/ffi-Q-purified water (Millipore Corp.); solvents filtered through a 0.45 urn Whatman nylon filter just before use; Waters Alliance system with a 486 tunable absorbance detector or Waters system consisting of a 600S controller, 616 pump, and a 996 photodiode array detector; for anion exchange, (3) . The reported procedure [21] with a reaction time of 24 h resulted in formation of decomposition products; the reaction was nearly complete after 3.5h (TLC (CH 2 Cl 2 /MeOH 3:1): i? f 0.42). Further, much solid product was discarded in the filtration of the hot reaction mixture following the literature workup. The procedure was improved as follows: According to [21] , 5'-0-(p-tolylsulfonyl)thymidine (75.7 mmol, 30.0 g) was prepared and then suspended in dry MeCN (450 ml). DBU (1.1 equiv., 83.32 mmol, 12.66 g, 12.44 ml) was added and the mixture refluxed for 3.5 h. Then more DBU (0.1 equiv, 1.2 ml) was added, the mixture refluxed for 1 more h, then cooled to r.t., and filtered, and the filtrate collected. The solid was refluxed with MeOH (150 ml) for 5 min and the mixture filtered while hot. The solid was again refluxed with MeOH (50 ml) for 5 min and filtered. The combined filtrates were evaporated and triturated with MeCN. The solid product (9.86 g) was dried in vacuo overnight. The MeCN filtrate obtained above was evaporated, acetone (150 ml) added, and the mixture kept for several hours. The product (1.60 g) was isolated as long needles and dried in vacuo. The products were combined (11.5 g, 68%). 'H-NMR (D 2 0/CD 3 OD): 1.74 (s, Me-C(5)); 2.21-2.52 (m, 2H~C(2')); 4.00 2'-Deoxy-5-methylisocytidine (Id). The yield of the reported procedure [4] was greatly improved by the use of a 600-ml pressure reactor (heater, mechanical stirrer; Parr instrument) which also allowed the reaction to be easily scaled up: Compound 3 (43.0 mmol, 9.63 g) was added to MeOH saturated at 0° with NH 3 (250 ml), and the mixture was placed in the pressure reactor and heated to 103° for 4 h. The reactor was cooled to 0° and opened, the solvent evaporated and the solid product taken up in MeCN and filtered. The white powder (10.3 g, 99 %) was dried in vacuo overnight. 'H-NMR (D 2 0/CD 3 OD): 1.61 (s, Me); 2.20 (m, 2H-C(2')); 3.58 (m, 2H-C(5')); 3.80 (m, H-C(4')); 4.21 (m, 1H-C(3')); 5.67 (f, H-C(l')); 7.39 (s, H-C(6)). 13 C-NMR (D 2 0/CD 3 0D): 13.7; 39.2; 61.7; 71.0; 87.9; 89.7; 115.9; 137.3; 155.9; 174.9.
2,5'-Anhydrothymidine
N-Benzoyl-2'-deoxy-5-methylisocytidine (le). A modified literature procedure [4] was inimicable to large-scale synthesis because of the large excess of PhCOCl required and the associated cumbersome purification; the excess of benzoyl chloride required could be reduced by addition of 4-(dimethylamino)pyridine (DMAP): Compound Id (1.77 mmol, 4.27 mg) was dissolved in anh. pyridine (15 ml) and DMAP (0.5 equiv., 0.886 mmol, 108 mg).
PhCOCl (5 equiv., 8.86 mmol, 1.03 ml) and Et 3 N (5 equiv., 8.86 mmol, 1.23 ml) were added at 0°. The mixture was stirred at r.t. for 45 min (TLC (CHCl 3 /MeOH 9:1): R r 0.87). Aq. NaHC0 3 soln. was added at 0°, adjusting the pH to 7. The soln. was stirred at r.t. for 30 min and then extracted with CHC1 3 (3 x 50 ml). The combined org. layers were washed (NaHC0 3 soln. and H 2 0), dried (Na 2 S0 4 ), and evaporated. The residue was dissolved in pyridine/MeOH 3:1 (9 ml), and a soln. of 9 equiv. NaOH (16.0 mmol, 638 mg) in H 2 0/MeOH 1:1 (20 ml) was added at 0°. After 10 min stirring at r.t., phosphate buffer soln. (5 ml) was added and the mixture evaporated. .
The reported procedure [4] (12 h at r.t.) gave mainly unreacted starting material le, even after a 20 h reaction time; better results were achieved at higher temp., with increased excess of (MeO) 2 TrCl, and by extraction with AcOEt instead of Et 2 0. Thus, to a soln. of le (1.54 mmol, 530 mg) in dry pyridine (20 ml) and DMAP (0.25 equiv., 0.384 mmol, 46.8 mg), Et 3 N (2 equiv., 3.1 mmol, 310 mg, 0.43 ml) and (MeO) 2 TrCl (1.8 equiv., 2.77 mmol, 936 mg) were added. The mixture was stirred at 40° for 3.5 h and at r.t. for 1 h. MeOH (3 ml) was added to quench the reaction, followed by aq. NaHC0 3 soln. (50 ml). The mixture was extracted with AcOEt (1 x 50 ml, 3 x 30 ml), the extract dried (Na 2 S0 4 ) and evaporated, and the residue purified by CC (CH 2 (6) 
W-Benzoyl-2'-deoxy-5'-0-(4,4'-dimethoxytrityl)-5-methylisocytidine 3' -0-(2-Cyanoethyl Diisopropylphosphoramidite) (lc)
. The reaction time of the reported procedure [4] was shortened to avoid formation of decomposition products, and the product was purified by reprecipitation to remove traces of phosphoramidite by-products: A soln. of If (co-evaporated from MeCN; 6.16 mmol, 3.98 g) in CH 2 C1 2 was cooled to 0°, and (i-Pr) 2 EtN (5.5 equiv., 33.9 mmol, 4.37 g, 5.89 ml) and 2-cyanoethyl diisopropylphosphoramidochloridite (1.4 equiv., 8.62 mmol, 2.04 g, 2.01 ml) were added via syringe. The mixture was stirred for 10 min at 0° and then 30 min at r.t. Aq. NaHC0 3 soln. (100 ml) was added and the mixture extracted with CH 2 Cl 2 /Et 3 N 98:2 (3 x 70 ml). The org. layer was dried (Na 2 S0 4 ) and evaporated and the residue purified by CC (CH 2 Cl 2 /AcOEt/Et 3 N 7:3:1; R, 0.84 and 0.86, 2 diastereoisomers). The product was dissolved in CH 2 C1 2 (10 ml), this soln. added slowly dropwise to strongly stirred hexane (700 ml) at r.t., the mixture decanted, and the solid product dried in vacuo: pale-yellow foam (3.86 g, 74% [18] [23], Id (30.9 mmol, 7.45 g) was coevaporated with DMF and then suspended in dry DMF (150 ml). AT.iV-Diisobutylformamide dimethyl acetal (1.5 equiv., 46.4 mmol, 9.41 g) was added, and the suspension became a clear soln. within 10 min. It was stirred at r.t. for 1 h. Then MeOH (5 ml) was added and the mixture evaporated. 10 .71 g) was co-evaporated with pyridine and dissolved in dry pyridine (150 ml). DMAP (0.25 equiv., 7.05 mmol, 860 mg), (MeO) 2 TrCl (1.15 equiv., 32.4mmol, 11.0 g; 11.6 g, 95%), and Et 3 N (2 equiv., 56.4 mmol, 7.84 ml) were added, and the mixture was stirred at r.t. for 2.5 h. MeOH (5 ml) was added and the mixture evaporated. The residue was partitioned in aq. NaHC0 3 soln./AcOEt and extracted with AcOEt (3 x 200 ml). The combined org. layer was dried (Na 2 S0 4 ) and evaporated and the residue purified by CC (silica gel, AcOEt/MeOH/Et 3 (6) (11) . As described for similar reactions [15] , lc (1 mmol, 847 mg) was dissolved in MeCN (5 ml), and 1/f-tetrazole (0.5 mmol, 35 mg) in H 2 0 (0.1 ml) was added. The mixture was stirred at r.t. for 1.5 h and then evaporated. The residue was extracted (NaHC0 3 soln./AcOEt), the org. layer dried (Na 2 S0 4 ) and evaporated, and the residue purified by reprecipitation from CH 2 C1 2 into hexanes (659 mg, 0. Nucleoside lm can be employed for formamidine protection and further for phosphoramidation. 2'-Deoxyisoguanosine (2a) was prepared from 2-amino-2'-deoxyadenosine (7a) in 81 % yield using a slightly modified literature method [24] . 
2-Deoxy
Compound 2b (0.775 mmol, 315 mg) was co-evaporated with pyridine and dissolved in anh. THF (15 ml). Et 3 N (3equiv., 2.32 mmol, 0.323 ml) and Me 3 SiCl (3 equiv., 2.32 mmol, 0.295 ml) were added, and the mixture was stirred at r.t. overnight (15 h). MeOH (2 ml) was added and the mixture evaporated. The residue was extracted (dil. NaHC0 3 soln./AcOEt) and the org. layer dried (Na 2 S0 4 ) and evaporated. 
2'-Deoxy-N 6 -[(diisobutylamino)methylidene]-0 2 -(diphenykarbamoyl)isoguanosine (7c). a)
From 7b. To a soln. of 7b (0.445 mmol, 332 mg) in THF (10 ml), 1M BU 4 NF in THF (2.2 equiv., 0.98 mmol, 0.98 ml) was added. The mixture was stirred at r.t. for 1.5 h and then evaporated. The residue was extracted (H 2 0/CHC1 3 ), the org. layer dried (Na 2 S0 4 ) and evaporated, and the product purified by CC (CHCl 3 /MeOH 9:1; R, 0.38): off-white foam (238 mg, 89%). b) From 9c. To a soln. of 9c (2.34 mmol, 1.97 g) in anh. THF (100 ml), 1M BU 4 NF in THF (2.2 equiv., 5.15 mmol, 5.15 ml) was added. The mixture was stirred at r.t. for 2 h and then evaporated. The residue was diluted with H 2 0 (50 ml) and extracted with CHC1 3 . The org. layer was dried (Na 2 S0 4 ) and evaporated, and the residue purified by CC (silica gel, CHCl 3 (8) 
2'-Deoxy-'H 6 -[(diisobutylamino)methylidene]-S'-(4,4'-dimethoxytrityl)-0 2 -(diphenylcarbamoyl)isoguanosine
(7d). Compound 7c (2.08 mmol, 1.25 g) was co-evaporated with pyridine, dissolved in anh. pyridine (50 ml) and DMAP (0.25 equiv., 0.521 mmol, 63.5 mg), (MeO) 2 TrCl (1.8 equiv., 3.75 mmol; 1.34 g, 95%) and Et 3 N (3 equiv., 6.25 mmol, 0.869 ml) were added. The mixture was stirred at r.t. for 4.5 h, then MeOH (5 ml) was added and the mixture evaporated. The residue was diluted with AcOEt and extracted (aq. NaHC0 3 soln./AcOEt), the combined org. layer dried (Na 2 S0 4 ) and evaporated, and the residue purified by CC (silica gel, CHCl 3 /MeOH 98. Isoguanosine (2g). To a suspension of 2-aminoadenosine (7f; 18 mmol, 5.0 g) in H 2 0 (160 ml) at 50°, NaN0 2 (3.86 equiv., 68.4 mmol, 4.72 g) in H 2 0 (30 ml) was added. Then, AcOH (6.93 equiv., 123 mmol, 7.02 ml) was added dropwise at 50°. The resulting clear soln. was stirred for 5 min and then diluted with H 2 0 (150 ml). Cone, aq. ammonia was added to pH 8, the mixture evaporated, and the remaining solid washed with H 2 0: light-yellow powder (4.59 g, 91.4%). 'H-NMR ((D 6 )DMSO): 3.50-3.74 (m, 2H-C(5')); 3.98 (m, H-C(4')); 4.12 (m,H-C(3'))l 4.54 (m, H-C(2')); 5.69 (m, H-C(l')); 7.97 (s, H-C(8)). 13 ) was co-evaporated with pyridine followed by DMF and suspended in dry DMF (100 ml). JV.JV-Diisobutylformamide dimethyl acetal (1.4 equiv., 22.7 mmol, 4.61 g) was added, the mixture stirred at r.t. for 23 h, then MeOH (3 ml) added, and the mixture evaporated. (8) 
-[(Dnsobutylamino)methylidene]-3',5'-0-(lJ,3,3-tetraisopropyldisiloxane-l,3-diyl)isoguanosine (8).
Compound 2d (0.761 mmol, 321 mg) was co-evaporated with pyridine and dissolved in dry pyridine (5 ml), 1,3-dichIoro-l,l,3,3-tetraisopropyldisiloxane (1.1 equiv., 0.837 mmol, 0.268 ml) added, and the mixture stirred at r.t. for 6 h. Aq. NaHC0 3 soln. (10 ml) was added and the mixture extracted (CHC1 3 ). The combined org. layer was dried (Na 2 S0 4 ) and evaporated and the residue used for NMR analysis: mixture of desired 8 and the corresponding 5'-0-(3-hydroxy-l,l,3,3-tetraisopropyldisiloxan-l-yl) compound 2e. Separation was possible but the yield was too poor for large-scale use.
Alternatively, according to [25] , 2h (0.3507 mmol, 148 mg) was co-evaporated with pyridine and dissolved in dry DMF (5 ml), Iff-imidazole (4 equiv., 1.40 mmol, 95.4 mg) and l,3-dichloro-l,l,3,3-tetraisopropyldisiloxane (1.1 equiv., 0.386 mmol, 0.123 ml) were added, and the mixture was stirred at r.t. until the reaction was complete (30 min). Aq. NaHC0 3 soln. (10 ml) was added and the mixture extracted (CHC1 3 ). The combined org. layer was dried (Na 2 S0 4 ), and evaporated and the residue used for NMR analysis: 8/2e. N 6 
-[(Diisobutylamino)methylidene)'-2',3' ,5'-tris-O-(trimethyhilyl) isoguanosine (2i)
. Compound 2h (8.23 mmol, 3.48 g) was co-evaporated with pyridine and dissolved in anh. THF (100 ml). Et 3 N (4 equiv., 32.9 mmol, 4.58 ml) and Me 3 SiCl (4 equiv., 32.9 mmol, 4.18 ml) were added, and a white precipitate was formed immediately. The mixture was stirred at r.t. overnight (13 h). TLC (CHCl 3 /MeOH 9:1): R t 0.48 (2i); 0.27 (starting material). MeOH (2 ml) was added, the mixture evaporated, dil. aq. NaHC0 3 soln. added, and the mixture extracted with AcOEt. The org. layer was dried (Na 2 S0 4 ), the solvent evaporated, and the obtained light-yellow foam (5.04 g, 96%) used in the next step without further purification. 'H-NMR (CDC1 3 ): 0.10, 0.14, 0. 
'H 6 -[(Diisobutylamino)methylidene]-0 2 -(diphenylcarbamoyl)-2',3',5'-tris-0-(trimethylsilyl)isoguanosine(Jg).
Compound 2i (7.91 mmol, 5.04 g) was co-evaporated with pyridine and dissolved in anh. pyridine (100 ml). (i-Pr) 2 EtN (1.7 equiv., 13.4 mmol, 2.34 ml) and diphenylcarbamoyl chloride (2 equiv., 15.8 mmol, 3.66 g) were added. The dark-orange soln. was stirred at r.t. for 2.25 h, then dil. aq. NaHC0 3 soln. added with ice-bath cooling, and the mixture extracted with CHC1 3 . The org. layer was dried (Na 2 S0 4 ) and evaporated and the residue purified by CC (CH 2 Cl 2 /MeOH 98.5:1. (8) , 7 um, 4.6 x 250 mm), using either of the two gradients with A = 25 HIM Tris ■ HC1 (pH 7.5/MeCN 9:1 and B = 25 DIM Tris ■ HC1 (pH 7.5) 2M NaCl/MeCN 9:1 or C = 20 mM K 3 P0 4 (pH 6.0) and D = 20 mM K 3 P0 4 (pH 6.0), 2M KC1; flow rate 0.5 ml/min. For anal, purposes, 0.1 A 160 units were injected. Semi-prep, separations were done with the 4.6-mm diameter column as well, by injecting up to 6 A 160 units.
-[(Diisobutylamino)methylidene]-0 2 -(diphenylcarbamoyl)-2-0-(phenoxythiocarbonyl)-3',5'-0-(l,l,3,3-tetraisopropyldisiloxane-l,3-diyl)isoguanosine (9b
Anal. Reversed-Phase HPLC. Oligonucleotides were analyzed by reversed-phase HPLC with a Waters Corporation column (Nova-Pak C 1S 60A, 4 um, 3.9 x 150 mm), using a gradient with A = 100 mM (Et 3 NH)OAc (pH 7.0) and B = MeCN; flow rate 0.5 ml/min; 0.1 A 260 units were injected.
Semiprep. Reversed-Phase HPLC. After semiprep. ion-exchange HPLC with oligonucleotides, the solvent of collected fractions was lyophilized. The solns. were then further purified with a Waters Corporation column (Nova-Pak HRC 18 60A, 6 urn, 7.8 x 300 mm), using a gradient with A = 25 mM (Et 3 NH)OAc (pH 7.0) and B = MeCN; flow rate 2.2 ml/min.
Reversed-Phase HPLC for Analysis of Nucleosides. Following digestion of oligonucleotides, the component nucleosides were separated by reversed-phase HPLC with a Waters Corporation column (Nova-Pak C 1S 60 A, 4 (im, 3.9 x 150 mm), using a gradient with A = 50 mM K 3 P0 4 (pH 7.0) and B = 50 mM K 3 P0 4 (pH 7.0)/MeOH 2:1; flow rate 0.5 ml/min. Order of eluting of 2'-deoxynucleosides:
Oligonucleotide Synthesis. Bottles to contain non-standard base phosphoramidites for the DNA synthesizer were washed, rinsed with acetone, and heated overnight at 120°. The bottles were then allowed to cool overnight in a dessicator over P 2 O s and under vacuum of < 1 Torr. IsoC d phosphoramidite was introduced and the bottles containing phosphoramidite were again placed in the dessicator under vacuum overnight.
Oligonucleotide synthesis was performed by the DNA Synthesis Core of the University of Florida on a PerSeptive Biosystems Expedite 8900 synthesizer, at the 0.2-umol scale. The synthesis was done using the manufacturer's recommended procedure, except the concentrations of standard phosphoramidites were half the manufacturer's recommended concentration. All chemicals were from PerSeptive Biosystems. DNA Membrane 0.2 um columns, also from PerSeptive, containing the 3'-terminal base of the desired oligonucleotide, were used (part numbers for each base: C = GEN050014, G = GEN050024, T = GEN050026, A = GEN050004). Anh. MeCN from Glen Research (part number 40-4050-45) was used to dilute the phosphoramidites (0.5 g in 10 ml for standard bases, 0.15 g in 1.5 ml for non-standard bases).
The synthesis protocols used are below. isoC d Phosphoramidite was coupled using the standard protocol, and isoG d phosphoramidite was coupled with an extended (600 s) coupling time.
At the completion of the synthesis, oligonucleotides were deprotected by incubating in 30 % aq. ammonium hydroxide (1.5 ml) at 55° for 12 h. The sample was then centrifuged and the supernatant removed and dried to a pellet. After drying, 0.7 mM NaOAc (0.3 ml) was added, the soln. vortexed, and EtOH added (1 ml) at -20°. This soln. was stored at -20° for 15 min before being centrifuged (15000 g, 20 min). The supernatant was discarded and the pellet suspended in 80% EtOH/H 2 0 (1 ml) and centrifuged again (15000 g, 20 min). The desalted oligonucleotide was then redissolved in 10 mM Tris ■ HC1, 0.4 mM EDTA, pH 7.7 (0.5 ml).
Coupling Efficiency by (MeO) 2 Tr Monitoring. A short oligomer having the sequence 5'-d(TTTTT-XXXXXTTTTT)-3' (X = non-standard base) was synthesized at 0.2-umol scale using the phosphoramidite to be evaluated. (MeO) 2 Tr Release at each coupling was monitored using the trityl viewer on an Expedite 8909 synthesizer. The coupling efficiency of each of the three sections (T 5 , X 5 , and T 5 ) was then determined by using 100 • 2 m , where m is the slope of the linear regression line of natural logarithm of the absorbance value vs. the coupling number.
Enzymatic Digestion of Oligonucleotides. The enzymes used were alkaline phosphatase from bovine calf intestine (18.2 prot mg/ml in 50% glycerol, 5 mM MgCl 2 , and 0.1 mM ZnCl 2 , pH 7.5) and phosphordiesterase I from Crotalus durissus terrificus venom (0.16 mg/ml in 50% glycerol, 5 mM Tris ■ HC1, pH 7.5). A stock soln. of alkaline phosphatase was prepared by adding enzyme soln. accuracy of replicating oligonucleotides in the presence of unnatural nucleotides. A proof of concept is obtained using pseudo-thymidine (\|/T; 1), the C-nucleoside analog of thymidine, as an unnatural substrate. The conformational properties of 1 arising from the carbon-carbon bond between the sugar and the base make it an interesting probe for the importance of conformational restraints in the active site of polymerases during primer elongation. From a pool of commercially available thermostable polymerases, the assay identified Taq DNA polymerase as the most suitable enzyme for the PCR amplification of oligonucleotides containing 1. Subsequent experiments analyzing processivity and fidelity of Taq DNA polymerase acting on 1 are presented.
Introduction:
The expansion of the nucleic acid-based chemistry and biology by novel, functionalized nucleotides and non-standard base pairs is driven by the possibility to identify RNA and DNA molecules with new catalytic and binding properties [Tarasow, 1997 #939] 
Even when the pausing is modest, it can have consequences in a PCR amplification, where copies must be made of copies, and pausing ocurs at each round of copying.
For these reasons, polymerases optimized to handle an expanded genetic alphabet need to be found by experiment. To date, polymerases have been screened using gel-based assays that allow examination of tens to hundreds of variants. These experiments have detected polymerases with improved ability to accept non-standard bases (need reference xxx), and a crude statistical evaluation of the results suggests that satisfactory polymerases will be attained, not after millions of variants are inspected, but after thousands are inspected. The goal of a polymerase-based molecular biology of an expanded genetic alphabet is therefore accessible, but only if a higher throughput screen is developed. 
Material and Methods
Chemical synthesis of pseudo-thymidine y/T (1) and y/TTP (3)
The phosphoramidite of pseudo-thymidine (\|/T, 1) was prepared from pseudouridine [Bhattacharya, 1995 . The triphosphate 3 (\|/TTP) of 1 was synthesized from 3'-acetylpseudothymidine, using the procedure by Ludwig and Eckstein [Ludwig, 1989 #47] 
Standing Start Experiments and PCR amplification
The qualitative fidelity of Taq DNA polymerase was investigated by standing-start experiments and PCR amplification over 10 cycles. Primers with a 5'-32 P-label were obtained by enzymatic phosphorylation with polynucleotide kinase (New England Biolabs) and y-32 P ATP (Amersham, >5000 Ci/mmol) and were ethanol-precipitated twice. After mixing primer (4 pmol), template (5 pmol) ( Figure 3A) , the corresponding dNTP (200 uM), and reaction buffer (supplied with polymerase), the enzyme was added on ice and the sample cycled once (1 minute, 94°C; 30 seconds, 55°C; 10 minutes, 72°C). The reaction was quenched with EDTA and ethanol-precipitated before loaded on a 10% PAGE gel (7 M urea). The gel was analyzed with the Molecularlmager® (BioRad).
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For the PCR amplification experiments, primer (1 uM each, forward primer was 5'-P labeled) and template (20 nmol The scintillation proximity assay (SPA™, AmershamPharmacia Biotech, Arlington Height, IL) [Cole, 1996 ] detects the incorporation of tritium-labelled dNMP into a product that is attached to a streptavidin-coated plastic beads, which contain a scintillant. Because of the relatively low energy of the tritium decay particle, radiolabel is counted more efficiently when it decays in the vicinity of the scintillant. The primer is 5'-biotinylated, and binds with the template to the bead with high affinity. To test the screen, we looked for polymerases that could handle pseudothymidine in the template (1). The C-nucleoside analog of thymidine (2) Measurements of counts per minute for a given reaction was reproducible within 10%.
As a proof of concept, a set of commercially available thermostable polymerases suitable for the polymerase chain reaction were then screened for their ability to incorporate 1 using the P/T 21/30 complex. A set of five reactions was run for each polymerase. After quenching with EDTA, the amount of tritium incorporation was determined by scintillation counting on SPA beads ( Figure 1C ).
Interestingly, misincorporation correlated directly with the exonuclease activity of the polymerase. Proofreading is usually viewed as a mechanism to ensure fidelity of DNA replication; 8
with the unusual nucleotide, proofreading may offer a mechanism for lowering the fidelity for Vent, Deep Vent, Pfu, and the Pwo DNA polymerases. Based on previous observations that polymerases pause after formation of base pairs involving unnatural nucleotides, we hypothesize that the halt allows the exonuclease activity (k_i, Figure 2 ) to become kinetically competent, resulting in removal of the nucleotide at position 25 from the primer. Upon repetition of the polymerization step (k+i) with a fresh nucleoside triphosphate, the pausing will repeat since the causative factor, the unnatural nucleotide, is located in the template. Eventually, the stalled complex either disassociates (k 0 ff) or is extended beyond the "misincorporation site" (k+2). However, the energetic advantage of the correct hydrogen-bonding partner, contributing to the specificity of correct nucleotide incorporation opposite 1 in the template becomes statistically insignificant, resulting in increased misincorporation.
Conversely, polymerases with reduced or no exonuclease activity (Taq, Tth, 9°N, Vent (exo"), Deep
Vent (exo")) will favor the incorporation of the correct nucleoside triphosphate, based on the absence of destabilization of the newly forming base pair resulting from incorrect hydrogen bonding pattern.
The significance of the exonuclease activity is particularly apparent when comparing the primer extension of Vent and Deep Vent DNA polymerase with their (exo')-mutants.
Standing start experiments:
Based on the screening using the scintillation proximity assay, the DNA polymerases from The only nucleoside triphosphate misincorporated to a significant extent was dATP (xxx Stefan;did I get this right?). The extended primer was most likely the result of non-template directed polymerization by Taq DNA polymerase, creating a 3'-A overhang.
Steady-state kinetics of y/T-incorporation by gel fidelity assay
A quantitative comparison of the efficiency of incorporation of \|/T and its natural competitors was made by measuring the single-nucleotide insertion by varying the dNTP concentration under single-turnover conditions. Applying the same primer-template complex as above (P/T 24/30), a series of kinetic studies was carried out using steady-state methods [Goodman, 1993 #952][Creighton, 1995 #1369]. Based on the above qualitative findings, kinetic data were determined only for the possible competitors and 1 itself. The insertion of dATP and dGTP opposite \j/T in the template and the incorporation of TTP, \|/TTP, and dATP opposite dA were studied. Kinetic parameters derived from the data are presented in Table 1 . The insertion of dATP opposite V}/T in the template is 50-fold more efficient than insertion of dGTP. This discrimination is smaller than that observed with standard nucleotides, which show discrimination ratios between 1 xlO and 1 xlO 4 . In the opposite direction, incorporation of \|/TTP opposite dA in the template is only 2-fold less efficient than TTP, the natural hydrogen bonding partner of dA. The insertion of dATP, on the other hand, is 3 xl0 2 -fold lo\ polymerization.
2
3 xlO -fold lower and, as suggested previously, probably the result of non-template specific
PCR amplification
Once performance with good fidelity and efficiency under single nucleotide incorporation conditions was achieved, primer elongation by Taq DNA polymerase under PCR-like conditions was tested. A reaction mixture containing a standard oligonucleotide (51-mer; Figure 4A ) flanked by the T3-and the T7-primer binding sequence was prepared and PCR amplified in the presence of dATP, dCTP, dGTP, and \|/TTP. Two control reactions, one substituting \|/TTP with standard TTP, the other performed in the absence of any thymidine analog, were run simultaneously. A sample was taken after each cycle and analyzed by PAGE ( Figure 4B ). The reaction mixture lacking thymidine or its analog generated no full-length product. The primer extension reaction was terminated completely at the position of the first adenosine in the template. In the presence of \|/TTP, the desired full-lengtholigonucleotide represented the primary product. Although up to three \|/T's in succession have to be incorporated in order to produce full-length product, only a small fraction of the extended primer appeared as an early termination product. Further PCR amplification up to 10 cycles gave similar results (data not shown) and suggested that Taq DNA polymerase could be used for PCR-like amplification of sequences containing \|/T.
Amplification fidelity / Sequencing
In addition to the evidence of \|/T-incorporation by Taq DNA polymerase under conditions of PCR amplification, further proof for sequence-specific amplification of an oligonucleotide in the presence of \|/TTP was sought. Modifying the original PCR protocol, the T7 primer was replaced by its 5'-biotinylated analog. After the regular PCR cycles, the amplified material was loaded onto a streptavidin column and washed. Single-stranded oligonucleotides were isolated by elution with sodium hydroxide solution and purified from the excess primer by PAGE. This material was used directly for Saenger dideoxy-sequencing and Maxam-Gilbert sequencing, as well as in enzymatic digestion. A complete digestion of the PCR product into the nucleosides by phosphodiesterase and alkaline phosphatase followed by quantification by reverse phase HPLC analysis gave the predicted ratio of nucleosides. The dideoxy-sequencing of the PCR product confirmed sequence identity with the original template ( Figure 5A ). Excluding the first few positions after the primer which could not be read conclusively due to high background, the sequence pattern was consistent with the original template. The purine/pyrimidine distinction, seen in Maxam-Gilbert sequencing ( Figure 5B), also indicated identical sequences after 10 cycles of PCR amplification. The positions of \j/T were identified easily by the missing bands in the C+T pattern. Clearly, the C-nucleoside does not undergo strand cleavage upon hydrazine/piperidine treatment and therefore does not appear as a distinct band in the sequencing gel.
Conclusions
In the present paper, we have successfully tested a new in vitro screening assay for thermostable DNA polymerases. The combination of a set of primer extension reactions and the SPA technology for its rapid and simple quantification represents a novel method to search for polymerases 11 that can utilize functionalized or structurally modified nucleotides. The method is applicable to any nucleoside analog, whether integrated in an oligonucleotide or present as the triphosphate. To further simplify and speed up the procedure, the entire assay has been transferred into 96-well microtiter plates (Flashplates), making it suitable for high-throughput screening of protein libraries.
The best polymerase obtained from the screen was Taq require the experiments to be measured in parallel, these preliminary data may help addressing the question of the individual contribution of hydrogen bonding and geometry to the overall fidelity of DNA polymerases.
